No shock for USCOM
Wednesday, 08 October, 2008
Medical device company USCOM (ASX: USC) has reported that its USCOM 1A device improves management of septic shock in children, according to research published in Pediatrics.
The research was conducted at London's Great Ormond Hospital for Sick Children.
It showed that the USCOM device, which measures cardiac output, allowed earlier and more accurate detection of abnormalities in children admitted to intensive care with septic shock.
The researchers suggested that using USCOM may be an improvement on the current septic shock practice guidelines, and could allow more appropriate prescription of dugs for treatment.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
